Get started
Author

Ezgi Yağmur Tükel

Observed name: Tükel, Ezgi Yağmur
Observed institution: İzmir University of Economics
ORCID: 0000-0003-3769-5531
Observed ORCID: 0000-0003-3769-5531
OpenAlex ID: A5018872098
Integrated systems biology analysis of acute lymphoblastic leukemia: unveiling molecular signatures and drug repurposing opportunities
2024 · Betül Budak, Ezgi Yağmur Tükel, et al. · Annals of Hematology · 6
In Silico Drug Repurposing Against PSMB8 as a Potential Target for Acute Myeloid Leukemia Treatment
2024 · Ezgi Yağmur Tükel, Onur Ateş, et al. · Molecular Biotechnology · 4
Identification of potential inhibitors for drug resistance in acute lymphoblastic leukemia through differentially expressed gene analysis and in silico screening
2024 · Başak Özay, Ezgi Yağmur Tükel, et al. · Analytical Biochemistry · 3
In silico drug screen reveals potential competitive MTHFR inhibitors for clinical repurposing
2023 · Nazlıgül Keske, Başak Özay, et al. · Journal of Biomolecular Structure and Dynamics · 3
Correction to: Integrated systems biology analysis of acute lymphoblastic leukemia: unveiling molecular signatures and drug repurposing opportunities
2024 · Betül Budak, Ezgi Yağmur Tükel, et al. · Annals of Hematology
P345: in Silico Drug Repurposing Study and Molecular Signature Identification on Adult Acute Lymphoblastic Leukemia
2023 · Yagmur Kiraz Durmaz, Betül Budak, et al. · HemaSphere
In silico drug screen reveals potential competitive MTHFR inhibitors for clinical repurposing
2023 · Keske, Nazlıgül, Özay, Başak, et al. · Figshare
Works count: 7
Citation count: 16
H-index: 3
I10-index:
Year
Topic
Type